PLK1 POLO BOX DOMAIN INHIBITOR AND METHOD OF TREATING CANCER Read more about PLK1 POLO BOX DOMAIN INHIBITOR AND METHOD OF TREATING CANCER Canada3193855Filed on 2023-03-24
PLK1 POLO BOX DOMAIN INHIBITORS AND METHOD OF TREATING CANCER Read more about PLK1 POLO BOX DOMAIN INHIBITORS AND METHOD OF TREATING CANCER US Application 18/028,463Filed on 2023-03-24
PLK1 POLO BOX DOMAIN INHIBITOR AND METHOD OF TREATING CANCER Read more about PLK1 POLO BOX DOMAIN INHIBITOR AND METHOD OF TREATING CANCER Australia2021350736Filed on 2023-04-18
CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS USING A VLP-REPLICON Read more about CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS USING A VLP-REPLICON US Patent 12,049,639Filed on 2023-02-24
ANTI-KRAS-G12D T CELL RECEPTORS Read more about ANTI-KRAS-G12D T CELL RECEPTORS Israel301894Filed on 2023-04-03
Viral Methods Of T Cell Therapy Read more about Viral Methods Of T Cell Therapy Australia2023201224Filed on 2023-02-28
SINGLE DOMAIN ANTIBODIES TARGETING SARS CORONAVIRUS SPIKE PROTEIN AND USES THEREOF Read more about SINGLE DOMAIN ANTIBODIES TARGETING SARS CORONAVIRUS SPIKE PROTEIN AND USES THEREOF US Application 18/033,656Filed on 2023-04-25
Compositions and Methods for Treating Cancer with Anti-CD33 Immunotherapy Read more about Compositions and Methods for Treating Cancer with Anti-CD33 Immunotherapy US Application 17/820,724Filed on 2022-08-18
LIGANDS SPECIFIC FOR ASCT1 Read more about LIGANDS SPECIFIC FOR ASCT1 European Patent22306795.0Filed on 2022-12-06
ADAM17 BINDING MOLECULES AND USES THEREOF Read more about ADAM17 BINDING MOLECULES AND USES THEREOF US Application 17/437,065Filed on 2020-03-07